Global Liver Cirrhosis Therapeutics Drugs Market Size, Status and Forecast 2018-2025
- QYR2790501
- 100 Pages
- October 2018
- Medical Devices
This report focuses on the global Liver Cirrhosis Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liver Cirrhosis Therapeutics Drugs development in United States, Europe and China.
The key players covered in this study
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Roche
Bristol-Myers Squibb
Conatus Pharmaceuticals
Gwo Xi Stem Cell Applied Technology
Instituto Grifols
Intercept Pharmaceuticals
NGM Biopharmaceuticals
Norgine
Pharmicell
Salix Pharmaceuticals
Stempeutics Research
Market segment by Type, the product can be split into
Oral
Injection
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Liver Cirrhosis Therapeutics Drugs status, future forecast, growth opportunity, key market and key players.
To present the Liver Cirrhosis Therapeutics Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Liver Cirrhosis Therapeutics Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type (2013-2025)
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Liver Cirrhosis Therapeutics Drugs Market Size
2.2 Liver Cirrhosis Therapeutics Drugs Growth Trends by Regions
2.2.1 Liver Cirrhosis Therapeutics Drugs Market Size by Regions (2013-2025)
2.2.2 Liver Cirrhosis Therapeutics Drugs Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Liver Cirrhosis Therapeutics Drugs Market Size by Manufacturers
3.1.1 Global Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2013-2018)
3.1.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Liver Cirrhosis Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Liver Cirrhosis Therapeutics Drugs Key Players Head office and Area Served
3.3 Key Players Liver Cirrhosis Therapeutics Drugs Product/Solution/Service
3.4 Date of Enter into Liver Cirrhosis Therapeutics Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018)
4.2 Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018)
5 United States
5.1 United States Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
5.2 Liver Cirrhosis Therapeutics Drugs Key Players in United States
5.3 United States Liver Cirrhosis Therapeutics Drugs Market Size by Type
5.4 United States Liver Cirrhosis Therapeutics Drugs Market Size by Application
6 Europe
6.1 Europe Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
6.2 Liver Cirrhosis Therapeutics Drugs Key Players in Europe
6.3 Europe Liver Cirrhosis Therapeutics Drugs Market Size by Type
6.4 Europe Liver Cirrhosis Therapeutics Drugs Market Size by Application
7 China
7.1 China Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
7.2 Liver Cirrhosis Therapeutics Drugs Key Players in China
7.3 China Liver Cirrhosis Therapeutics Drugs Market Size by Type
7.4 China Liver Cirrhosis Therapeutics Drugs Market Size by Application
8 Japan
8.1 Japan Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
8.2 Liver Cirrhosis Therapeutics Drugs Key Players in Japan
8.3 Japan Liver Cirrhosis Therapeutics Drugs Market Size by Type
8.4 Japan Liver Cirrhosis Therapeutics Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
9.2 Liver Cirrhosis Therapeutics Drugs Key Players in Southeast Asia
9.3 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Type
9.4 Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Application
10 India
10.1 India Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
10.2 Liver Cirrhosis Therapeutics Drugs Key Players in India
10.3 India Liver Cirrhosis Therapeutics Drugs Market Size by Type
10.4 India Liver Cirrhosis Therapeutics Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Liver Cirrhosis Therapeutics Drugs Market Size (2013-2018)
11.2 Liver Cirrhosis Therapeutics Drugs Key Players in Central & South America
11.3 Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Type
11.4 Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Application
12 International Players Profiles
12.1 Gilead Sciences
12.1.1 Gilead Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.1.4 Gilead Sciences Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.1.5 Gilead Sciences Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.2.5 GlaxoSmithKline Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.3.5 Johnson & Johnson Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.4.4 Merck Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.4.5 Merck Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.5.4 Roche Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.5.5 Roche Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Details
12.6.2 Company Description and Business Overview
12.6.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.6.4 Bristol-Myers Squibb Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Conatus Pharmaceuticals
12.7.1 Conatus Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.7.4 Conatus Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.7.5 Conatus Pharmaceuticals Recent Development
12.8 Gwo Xi Stem Cell Applied Technology
12.8.1 Gwo Xi Stem Cell Applied Technology Company Details
12.8.2 Company Description and Business Overview
12.8.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.8.4 Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
12.9 Instituto Grifols
12.9.1 Instituto Grifols Company Details
12.9.2 Company Description and Business Overview
12.9.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.9.4 Instituto Grifols Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.9.5 Instituto Grifols Recent Development
12.10 Intercept Pharmaceuticals
12.10.1 Intercept Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Liver Cirrhosis Therapeutics Drugs Introduction
12.10.4 Intercept Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
12.10.5 Intercept Pharmaceuticals Recent Development
12.11 NGM Biopharmaceuticals
12.12 Norgine
12.13 Pharmicell
12.14 Salix Pharmaceuticals
12.15 Stempeutics Research
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Liver Cirrhosis Therapeutics Drugs Key Market Segments
Table Key Players Liver Cirrhosis Therapeutics Drugs Covered
Table Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Type 2013-2025
Figure Oral Figures
Table Key Players of Oral
Figure Injection Figures
Table Key Players of Injection
Table Global Liver Cirrhosis Therapeutics Drugs Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Liver Cirrhosis Therapeutics Drugs Report Years Considered
Table Global Liver Cirrhosis Therapeutics Drugs Market Size 2013-2025 (Million US$)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Regions 2013-2025 (Million US$)
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Regions 2013-2018 (Million US$)
Table Global Liver Cirrhosis Therapeutics Drugs Market Share by Regions 2013-2018
Figure Global Liver Cirrhosis Therapeutics Drugs Market Share by Regions 2013-2018
Figure Global Liver Cirrhosis Therapeutics Drugs Market Share by Regions 2018
Table Market Top Trends
Table Global Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Liver Cirrhosis Therapeutics Drugs Market Share by Manufacturers (2013-2018)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Share by Manufacturers in 2018
Table Global Liver Cirrhosis Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Liver Cirrhosis Therapeutics Drugs Product/Solution/Service
Table Date of Enter into Liver Cirrhosis Therapeutics Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Type (2013-2018)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Type (2013-2018)
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Application (2013-2018)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Market Share by Application (2013-2018)
Figure Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Application in 2017
Figure United States Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table United States Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table United States Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table United States Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table United States Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table United States Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table United States Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Figure Europe Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table Europe Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table Europe Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table Europe Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table Europe Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table Europe Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table Europe Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Figure China Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table China Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table China Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table China Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table China Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table China Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table China Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Figure Japan Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table Japan Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table Japan Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table Japan Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table Japan Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table Japan Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table Japan Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Figure Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Figure India Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table India Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table India Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table India Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table India Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table India Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table India Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Figure Central & South America Liver Cirrhosis Therapeutics Drugs Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Liver Cirrhosis Therapeutics Drugs Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Liver Cirrhosis Therapeutics Drugs Market Share (2017-2018)
Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Type (2013-2018) (Million US$)
Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Share by Type (2013-2018)
Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Size by Application (2013-2018) (Million US$)
Table Central & South America Liver Cirrhosis Therapeutics Drugs Market Share by Application (2013-2018)
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018) (Million US$)
Figure Gilead Sciences Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Merck Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Merck Recent Development
Table Roche Company Details
Table Roche Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Roche Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Bristol-Myers Squibb Recent Development
Table Conatus Pharmaceuticals Company Details
Table Conatus Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Conatus Pharmaceuticals Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Conatus Pharmaceuticals Recent Development
Table Gwo Xi Stem Cell Applied Technology Company Details
Table Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Gwo Xi Stem Cell Applied Technology Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Gwo Xi Stem Cell Applied Technology Recent Development
Table Instituto Grifols Company Details
Table Instituto Grifols Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Instituto Grifols Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Instituto Grifols Recent Development
Table Intercept Pharmaceuticals Company Details
Table Intercept Pharmaceuticals Revenue in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)(Million US$)
Figure Intercept Pharmaceuticals Revenue Growth Rate in Liver Cirrhosis Therapeutics Drugs Business (2013-2018)
Table Intercept Pharmaceuticals Recent Development
Table NGM Biopharmaceuticals Company Details
Table Norgine Company Details
Table Pharmicell Company Details
Table Salix Pharmaceuticals Company Details
Table Stempeutics Research Company Details
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Regions (Million US$) 2018-2025
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Regions (2018-2025)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size Share by Regions in 2025
Figure United States Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Europe Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Figure China Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Japan Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Figure India Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Liver Cirrhosis Therapeutics Drugs Market Size Forecast (2018-2025)(Million USD)
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Product (2018-2025) (Million US$)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Product (2018-2025)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Product in 2025
Table Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2018-2025) (Million US$)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Application (2018-2025)
Figure Global Liver Cirrhosis Therapeutics Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
